Boston Scientific, Johnson & Johnson Bury The Hatchet With $600 Million Settlement Boston Scientific has been in a lot of hot water since it acquired Guidant in 2006. With this settlement, it is finally making peace with Johnson & Johnson and moving on. by Dianne Depra
Healthy Living/Wellness Johnson & Johnson halts sale of power morcellators for fibroid surgery by Rhodi Lee
Healthy Living/Wellness FDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd time by Randell Suba